MYC and breast cancer: However, our laboratory has previously demonstrated in a mouse model of breast cancer that two oncogenic transgenes, TetO-KrasG12D and TetO-Myc, can be co-expressed in mammary tumors at levels similar to those observed in tumors from transgenic animals containing only one of the transgenes (Podsypanina et al., 2008).